Santarus

We are a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists or primary care physicians. Our current products are immediate-release formulations of omeprazole, a widely prescribed proton pump inhibitor, or PPI. PPIs are the most frequently prescribed drugs for the treatment of many upper gastrointestinal, or GI, diseases and disorders. We currently market ZEGERID® (omeprazole/sodium bicarbonate) Capsules and ZEGERID (omeprazole/sodium bicarbonate) Powder for Oral Suspension. These products are the first and only immediate-release oral PPIs approved by the U.S. Food and Drug Administration, or FDA, for commercial sale in the U.S. (see Products for more information). ZEGERID Capsules and ZEGERID Powder for Oral Suspension are being marketed in the U.S. by a field sales force of over 500 sales representatives who promote ZEGERID products in the primary detail position. Our sales force presence includes approximately 210 of our own field sales representatives and 170 field sales representatives under a co-promotion agreement with Otsuka America Pharmaceutical, Inc. In addition, our field sales force presence increased in early 2007 with the addition of approximately 140 contract sales representatives from inVentiv Commercial Services, LLC. The ZEGERID sales force calls on approximately 26,000 gastroenterologists and primary care physicians who are among the highest prescribing U.S. physicians for PPIs. In 2006 we reported net product sales of approximately $46 million, compared to 2005 net product sales of $13.7 million. These sales results were accomplished with only nine months of capsules sales and ZEGERID Capsules have quickly become our primary product offering. Our stock trades on the NASDAQ Global Market under the symbol "SNTS".

Contact Details: 10590 West Ocean Air Drive Suite 200 San Diego CA 92130 United States of America Tel: 858-314-5700 Fax: 858-314-5701 Email: contact@santarus.com WWW: www.santarus.com/

Loading...

Press Releases on Santarus:
Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger	23rd November, 2009	Anesiva, Inc.	SOUTH SAN FRANCISCO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced that Dr. Ted W. Love and Dr. David C. U'Prichard have agreed to join the Anesiva board
Santarus to Webcast Analyst Day and Investor Briefing Presentation on May 13	8th May, 2009	Santarus, Inc.	SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- Santarus, Inc. (Nasdaq: SNTS) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst day and investor
Abingdon Life Sciences, Inc. Announces Appointment of Charles H. Davis, RAC as Vice-President, Regulatory Science	8th September, 2008	Abingdon Life Sciences, Inc.	CARLSBAD, Calif., Sept. 8 /PRNewswire/ -- Abingdon Life Sciences, Inc. a Drug and Device Development Management Organization (DDMO) announced it has appointed Charles H. Davis, RAC as Vice

BioNews Results for Santarus:
Depomed Promotes William Callahan to Vice President of Operations	Yahoo! Canada:  Nov 18 2009 7:37PM Matching: santarus
Santarus, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released	PR inside:  Nov 13 2009 9:44AM Matching: santarus
News and FDA Updates for Monsanto (NYSE:MON), Santarus (NASDAQ:SNTS), S3 Investment (OTC:SIVC)	Los Angeles Chronicle:  Nov 12 2009 9:58AM Matching: santarus
News and FDA Updates for Monsanto (NYSE:MON), Santarus (NASDAQ:SNTS), S3 Investment (OTC:SIVC)	American Chronicle:  Nov 12 2009 7:53AM Matching: santarus
Positive Data from Two Investigator-Initiated Studies with Santarus' ZEGERID to Be Presented At ACG	Pharmacy Choice:  Nov 11 2009 3:36PM Matching: santarus
Promote your company here: BioNewsCast - Press Release Distribution	→View more Santarus news.

Santarus Clinical Trials:
Extension Study of Budesonide MMX™ 6mg in Maintenance Of Remission In Patients With Ulcerative Colitis

Santarus (SNTS) Financial information Links from Barchart
SNTS Quote from from Barchart.com
SNTS Chart from from Barchart.com
SNTS Profile from from Barchart.com
SNTS Opinion from from Barchart.com
→View more Santarus finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 841 times since April 2007, the link to the organisation's website has been followed 171 times

Recent Search Terms used to find this page: inventiv and santarus | who are santarus | santarus sales force zegerid | Abingdon Life Sciences Inc. Charles H. Davis email | SANTARUS IN az | ZEGERID (omeprazole/sodium bicarbonate) Capsules pdf | .

Search for more companies in San Diego

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Santarus